Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway

Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway

The acute kidney injury(AKI) caused by nephrotoxic drugs contributes to inflammation and oxidative injury in podocytes. Wedelolactone (WED), a natural compound, is found with activities as anti-inflammation, anti-oxidative, anti-free radical,and etc. In this present study, MPC-5 cells were exposed t...

Full description

Bibliographic Details
Main Authors:	Mao-mao Zhu, Long Wang, Dang Yang, Chao Li, Shi-ting Pang, Xing-hua Li, Ru Li, Bing Yang, Yuan-pei Lian, Liang Ma, Qing-lin Lv, Xiao-bin Jia, Liang Feng
Format:	Article
Language:	English
Published:	Elsevier 2019-09-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Wedelolactone Doxorubicin Podocyte Inflammation Oxidative stress
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332219316713

Similar Items

Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability
by: Liang Feng, et al.
Published: (2019-11-01)

Crocin Protects Podocytes Against Oxidative Stress and Inflammation Induced by High Glucose Through Inhibition of NF-κB
by: Sutong Li, et al.
Published: (2017-07-01)

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
by: Jin-yu Yang, et al.
Published: (2019-03-01)

Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells
by: Tereza Nehybová, et al.
Published: (2017-03-01)

Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway
by: Qiang Wan, et al.
Published: (2020-02-01)

Palladium(II)-Catalyzed Efficient Synthesis of Wedelolactone and Evaluation as Potential Tyrosinase Inhibitor
by: Huidan Huang, et al.
Published: (2019-11-01)

Development and Validation of an Ultra-Performance Liquid Chromatography Method for the Determination of Wedelolactone in Rat Plasma and its Application in a Pharmacokinetic Study
by: Qing Chen, et al.
Published: (2019-02-01)

KINETICS OF ULTRASOUND ASSISTED EXTRACTION OF WEDELOLACTONE FROM Eclipta alba
by: T. W. Charpe, et al.

The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice
by: Yongqiang Ai, et al.
Published: (2021-06-01)

Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy
by: Yuxiang Liu, et al.
Published: (2021-01-01)

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity
by: Xiaoping Wang, et al.
Published: (2020-05-01)

Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB
by: Ruimin Tian, et al.
Published: (2019-07-01)

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
by: Yongqiang Ai, et al.
Published: (2021-10-01)

Wedelolactone enhances osteoblastogenesis but inhibits osteoclastogenesis through Sema3A/NRP1/PlexinA1 pathway
by: Yanqiu Liu, et al.
Published: (2016-10-01)

Thymol alleviates AGEs-induced podocyte injury by a pleiotropic effect via NF-κB-mediated by RhoA/ROCK signalling pathway
by: Qinglian Wang, et al.
Published: (2020-01-01)

Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
by: Liping Zhu, et al.
Published: (2018-03-01)

Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding
by: Sarwar S, et al.
Published: (2020-09-01)

Simultaneous Analysis of Wnt and NF-κB Signaling Pathways in Doxorubicin Sensitive and Methotrexate Resistant PLC/ PRF/5 Cells
by: Nasrin Shojaie, et al.
Published: (2016-02-01)

NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity
by: Anji Xu, et al.
Published: (2020-10-01)

Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal
by: Shasha Song, et al.
Published: (2019-09-01)

Platelet-rich plasma inhibits Adriamycin-induced inflammation via blocking the NF-κB pathway in articular chondrocytes
by: Haijun Zhao, et al.
Published: (2021-06-01)

Overexpression of IκBα in cardiomyocytes alleviates hydrogen peroxide-induced apoptosis and autophagy by inhibiting NF-κB activation
by: Min Han, et al.
Published: (2020-06-01)

EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway
by: Ke-Wang Luo, et al.
Published: (2020-12-01)

The Expression Profile of Complement Components in Podocytes
by: Xuejuan Li, et al.
Published: (2016-03-01)

Optimization of supercritical fluid extraction and HPLC identification of wedelolactone from Wedelia calendulacea by orthogonal array design
by: Ajit A. Patil, et al.
Published: (2014-11-01)

Differential toxicities of triptolide to immortalized podocytes and the podocytes in vivo
by: Mengjie Sun, et al.
Published: (2019-01-01)

Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
by: Sanjeev Shukla, et al.
Published: (2015-01-01)

Beyond NF-κB activation: nuclear functions of IκB kinase α
by: Huang Wei-Chien, et al.
Published: (2013-01-01)

Role of monoubiquitylation on the control of IκBα degradation and NF-κB activity.
by: Elisa Da Silva-Ferrada, et al.
Published: (2011-01-01)

Understanding two inhibitors of NF-κB: A20 and IκBβ
by: De, Arnab
Published: (2014)

Characterization of Grouper NF-κB/IκB Complex Response to Nodavirus Infection.
by: Yu-LinTsai, et al.
Published: (2015)

Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility
by: Yehua Liu, et al.
Published: (2015-01-01)

Podocyte Pathology and Nephropathy
by: Sandra eMerscher, et al.
Published: (2014-07-01)

DDRGK1 regulates NF-κB activity by modulating IκBα stability.
by: Peng Xi, et al.
Published: (2013-01-01)

NF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer
by: Lluís Espinosa, et al.
Published: (2021-09-01)

Regulation of NF-κB and IRF signalling pathways at the level of I-κB kinases and their adaptors
by: Ryzhakov, Grigory
Published: (2007)

NF-κB and Disease
by: Paola Poma
Published: (2020-12-01)

NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
by: Carlota Colomer, et al.
Published: (2017-05-01)

PODOCYTES… WHATS UNDER YOURS? (PODOCYTES AND FOOT PROCESSES AND HOW THEY CHANGE IN NEPHROPATHY)
by: Chris Robert Neal
Published: (2015-02-01)

ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling
by: Qi Wu, et al.
Published: (2021-05-01)